ALDEYRA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.70 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 565.08K shares, a 13.25% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.14M shares, a 96.30% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 20.00K shares.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.61M shares, a 32.31% decline from fiscal 2024.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.38M shares, a 102.62% increase from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.17M shares, a 33.22% decline from fiscal 2022.
- ALDEYRA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.76M shares, a 81.97% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 565.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 2.70M shares 10-Q · filed 2026-08-06 | 2.70M shares derived: sum of 3 quarters · filed 2026-08-06 | 2.72M shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 2.14M shares 10-Q · filed 2026-05-07 | 2.14M shares derived: sum of 2 quarters · filed 2026-05-07 | 2.16M shares derived: sum of 3 quarters · filed 2026-05-07 | 2.66M shares derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 20.00K shares derived: sum of 2 quarters · filed 2026-02-27 | 518.97K shares derived: sum of 3 quarters · filed 2026-02-27 | 1.61M shares 10-K · filed 2026-02-27 | |
| 2025-09-30 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 518.97K shares derived: sum of 2 quarters · filed 2025-11-05 | 1.61M shares 10-Q · filed 2025-11-05 | 1.61M shares derived: sum of 4 quarters · filed 2025-11-05 | |
| 2025-06-30 | 498.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.59M shares 10-Q · filed 2025-08-07 | 1.59M shares derived: sum of 3 quarters · filed 2025-08-07 | 1.59M shares derived: sum of 4 quarters · filed 2025-08-07 | |
| 2025-03-31 | 1.09M shares 10-Q · filed 2025-05-14 | 1.09M shares derived: sum of 2 quarters · filed 2025-05-14 | 1.09M shares derived: sum of 3 quarters · filed 2025-05-14 | 1.36M shares derived: sum of 4 quarters · filed 2025-05-14 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 0.00 shares derived: sum of 2 quarters · filed 2025-02-28 | 274.68K shares derived: sum of 3 quarters · filed 2025-02-28 | 2.38M shares 10-K · filed 2025-02-28 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 274.68K shares derived: sum of 2 quarters · filed 2024-11-07 | 2.38M shares 10-Q · filed 2024-11-07 | 2.38M shares derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | 274.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 2.38M shares 10-Q · filed 2024-08-01 | 2.38M shares derived: sum of 3 quarters · filed 2024-08-01 | 2.38M shares derived: sum of 4 quarters · filed 2024-08-01 | |
| 2024-03-31 | 2.10M shares 10-Q · filed 2024-05-02 | 2.10M shares derived: sum of 2 quarters · filed 2024-05-02 | 2.10M shares derived: sum of 3 quarters · filed 2024-05-02 | 2.25M shares derived: sum of 4 quarters · filed 2024-05-02 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-07 | 144.71K shares derived: sum of 3 quarters · filed 2024-03-07 | 1.17M shares 10-K · filed 2024-03-07 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 144.71K shares derived: sum of 2 quarters · filed 2023-11-03 | 1.17M shares 10-Q · filed 2023-11-03 | 1.17M shares derived: sum of 4 quarters · filed 2023-11-03 | |
| 2023-06-30 | 144.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 1.17M shares 10-Q · filed 2023-08-03 | 1.17M shares derived: sum of 3 quarters · filed 2023-08-03 | 1.21M shares derived: sum of 4 quarters · filed 2023-08-03 | |
| 2023-03-31 | 1.03M shares 10-Q · filed 2023-05-04 | 1.03M shares derived: sum of 2 quarters · filed 2023-05-04 | 1.06M shares derived: sum of 3 quarters · filed 2023-05-04 | 1.43M shares derived: sum of 4 quarters · filed 2023-05-04 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 35.00K shares derived: sum of 2 quarters · filed 2023-03-09 | 406.24K shares derived: sum of 3 quarters · filed 2023-03-09 | 1.76M shares 10-K · filed 2023-03-09 | |
| 2022-09-30 | 35.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 406.24K shares derived: sum of 2 quarters · filed 2022-11-10 | 1.76M shares 10-Q · filed 2022-11-10 | 1.82M shares derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-06-30 | 371.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | 1.72M shares 10-Q · filed 2022-08-05 | 1.78M shares derived: sum of 3 quarters · filed 2022-08-05 | 1.86M shares derived: sum of 4 quarters · filed 2022-08-05 | |
| 2022-03-31 | 1.35M shares 10-Q · filed 2022-05-05 | 1.41M shares derived: sum of 2 quarters · filed 2022-05-05 | 1.49M shares derived: sum of 3 quarters · filed 2022-05-05 | 2.21M shares derived: sum of 4 quarters · filed 2022-05-05 | |
| 2021-12-31 | 60.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 135.00K shares derived: sum of 2 quarters · filed 2022-03-17 | 857.05K shares derived: sum of 3 quarters · filed 2022-03-17 | 965.17K shares 10-K · filed 2022-03-17 | |
| 2021-09-30 | 75.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | 797.05K shares derived: sum of 2 quarters · filed 2021-10-28 | 905.17K shares 10-Q · filed 2021-10-28 | 905.17K shares derived: sum of 4 quarters · filed 2021-10-28 | |
| 2021-06-30 | 722.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 830.17K shares 10-Q · filed 2021-08-05 | 830.17K shares derived: sum of 3 quarters · filed 2021-08-05 | 836.17K shares derived: sum of 4 quarters · filed 2021-08-05 | |
| 2021-03-31 | 108.11K shares 10-Q · filed 2021-05-06 | 108.11K shares derived: sum of 2 quarters · filed 2021-05-06 | 114.11K shares derived: sum of 3 quarters · filed 2021-05-06 | 353.91K shares derived: sum of 4 quarters · filed 2021-05-06 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 6.00K shares derived: sum of 2 quarters · filed 2021-03-11 | 245.80K shares derived: sum of 3 quarters · filed 2021-03-11 | 1.67M shares 10-K · filed 2021-03-11 | |
| 2020-09-30 | 6.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 245.80K shares derived: sum of 2 quarters · filed 2020-11-05 | 1.67M shares 10-Q · filed 2020-11-05 | 1.80M shares derived: sum of 4 quarters · filed 2020-11-05 | |
| 2020-06-30 | 239.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 1.66M shares 10-Q · filed 2020-08-06 | 1.79M shares derived: sum of 3 quarters · filed 2020-08-06 | 1.82M shares derived: sum of 4 quarters · filed 2020-08-06 | |
| 2020-03-31 | 1.42M shares 10-Q · filed 2020-05-07 | 1.55M shares derived: sum of 2 quarters · filed 2020-05-07 | 1.58M shares derived: sum of 3 quarters · filed 2020-05-07 | 1.76M shares derived: sum of 4 quarters · filed 2020-05-07 | |
| 2019-12-31 | 129.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 157.44K shares derived: sum of 2 quarters · filed 2020-03-12 | 337.79K shares derived: sum of 3 quarters · filed 2020-03-12 | 1.45M shares 10-K · filed 2020-03-12 | |
| 2019-09-30 | 28.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 208.36K shares derived: sum of 2 quarters · filed 2019-11-07 | 1.32M shares 10-Q · filed 2019-11-07 | 1.38M shares derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-06-30 | 180.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 1.29M shares 10-Q · filed 2019-08-09 | 1.35M shares derived: sum of 3 quarters · filed 2019-08-09 | 1.46M shares derived: sum of 4 quarters · filed 2019-08-09 | |
| 2019-03-31 | 1.11M shares 10-Q · filed 2019-05-10 | 1.17M shares derived: sum of 2 quarters · filed 2019-05-10 | 1.28M shares derived: sum of 3 quarters · filed 2019-05-10 | 1.61M shares derived: sum of 4 quarters · filed 2019-05-10 | |
| 2018-12-31 | 60.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | 170.00K shares derived: sum of 2 quarters · filed 2019-03-08 | 505.31K shares derived: sum of 3 quarters · filed 2019-03-08 | 1.33M shares 10-K · filed 2019-03-08 | |
| 2018-09-30 | 110.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 445.31K shares derived: sum of 2 quarters · filed 2018-11-14 | 1.27M shares 10-Q · filed 2018-11-14 | 1.28M shares derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-06-30 | 335.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 1.16M shares 10-Q · filed 2018-08-09 | 1.17M shares derived: sum of 3 quarters · filed 2018-08-09 | 1.18M shares derived: sum of 4 quarters · filed 2018-08-09 | |
| 2018-03-31 | 820.00K shares 10-Q · filed 2018-05-15 | 830.00K shares derived: sum of 2 quarters · filed 2018-05-15 | 845.00K shares derived: sum of 3 quarters · filed 2018-05-15 | 979.80K shares derived: sum of 4 quarters · filed 2018-05-15 | |
| 2017-12-31 | 10.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 25.00K shares derived: sum of 2 quarters · filed 2018-03-29 | 159.80K shares derived: sum of 3 quarters · filed 2018-03-29 | 899.34K shares 10-K · filed 2018-03-29 | |
| 2017-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 149.80K shares derived: sum of 2 quarters · filed 2017-11-09 | 889.34K shares 10-Q · filed 2017-11-09 | 926.84K shares derived: sum of 4 quarters · filed 2017-11-09 | |
| 2017-06-30 | 134.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 874.34K shares 10-Q · filed 2017-08-07 | 911.84K shares derived: sum of 3 quarters · filed 2017-08-07 | 989.00K shares derived: sum of 4 quarters · filed 2017-08-07 | |
| 2017-03-31 | 739.54K shares 10-Q · filed 2017-05-15 | 777.04K shares derived: sum of 2 quarters · filed 2017-05-15 | 854.20K shares derived: sum of 3 quarters · filed 2017-05-15 | 920.70K shares derived: sum of 4 quarters · filed 2017-05-15 | |
| 2016-12-31 | 37.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | 114.67K shares derived: sum of 2 quarters · filed 2017-03-30 | 181.16K shares derived: sum of 3 quarters · filed 2017-03-30 | 759.31K shares 10-K · filed 2017-03-30 | |
| 2016-09-30 | 77.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 143.66K shares derived: sum of 2 quarters · filed 2016-11-14 | 721.81K shares 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | 66.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | 644.65K shares 10-Q · filed 2016-08-10 | |||
| 2016-03-31 | 578.15K shares 10-Q · filed 2016-05-09 | ||||
| 2015-12-31 | 203.30K shares 10-K · filed 2016-03-30 | ||||
| 2014-12-31 | 264.19K shares 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | 109.04K shares 10-Q · filed 2014-11-12 | 264.19K shares derived: sum of 2 quarters · filed 2014-11-12 | 264.19K shares derived: sum of 3 quarters · filed 2014-11-12 | ||
| 2014-06-30 | 155.15K shares 10-Q · filed 2014-08-07 | 155.15K shares derived: sum of 2 quarters · filed 2014-08-07 | |||
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-06-11 | ||||
| 2013-12-31 | 542.61K shares 10-K · filed 2015-03-23 | ||||
| 2013-06-21 | 300.15K shares 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |